CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection

被引:43
作者
Fleuridor, R
Wilson, B
Hou, R
Landay, A
Kessler, H
Al-Harthi, L
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Div Infect Dis, Chicago, IL 60612 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1046/j.1365-2567.2003.01560.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant human natural killer T cells (NKT) express a restricted T-cell receptor (TCR) Valpha24Vbeta11 repertoire. These cells share both phenotypic and functional similarities between NK and T cells. Given the emerging role of NKT cells as critical cells in bridging the gap between innate and adaptive immunity, we examined their susceptibility to productive human immunodeficiency virus (HIV) infection by T-tropic, M-tropic, and primary isolates of HIV. We generated three human NKT cell clones (CA5, CA29, and CA31). Phenotypic characterization of these Valpha24(+) Vbeta11(+) clones indicated that they were predominately positive for CD4, CD161, HLA-DR, CD38, CD45RO, and CD95 expression. The NKT cell clones expressed significantly more surface CCR5 molecules/cell and lower CXCR4 molecules/cell than phytohaemagglutinin-stimulated peripheral blood mononuclear cells (PBMC). Consistent with the surface expression of CCR5 and CXCR4, the NKT clones were also selectively susceptible to HIV M-tropic, T-tropic, and primary isolate infection, as evaluated by both HIV p24 enzyme-linked immunosorbent assay and intracellular staining of HIV proteins. The amount of p24 production was dependent on the NKT clone studied and the HIV strain used. Clones CA29 and CA31 were also susceptible to HIV IIIB infection. The virions produced by these clones were able to productively infect PHA-stimulated PBMCs with the same kinetics as for primary infection of CD4(+) blast. Collectively, this data demonstrates that NKT cells can be a target for productive HIV infection but with a lag in the time to peak p24 production.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 42 条
[1]   Evidence for two subgroups of CD4-CD8- NKT cells with distinct TCRαβ repertoires and differential distribution in lymphoid tissues [J].
Apostolou, I ;
Cumano, A ;
Gachelin, G ;
Kourilsky, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2481-2490
[2]   Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls [J].
Apostolou, I ;
Takahama, Y ;
Belmant, C ;
Kawano, T ;
Huerre, M ;
Marchal, G ;
Cui, J ;
Taniguchi, M ;
Nakauchi, H ;
Fournié, JJ ;
Kourilsky, P ;
Gachelin, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5141-5146
[3]   Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production [J].
Baker, J ;
Verneris, MR ;
Ito, M ;
Shizuru, JA ;
Negrin, RS .
BLOOD, 2001, 97 (10) :2923-2931
[4]   Expression and selection of productively rearranged TCRβ VDJ genes are sequentially regulated by CD3 signaling in the development of NK1.1+ αβ T cells [J].
Baur, N ;
Nerz, G ;
Nil, A ;
Eichmann, K .
INTERNATIONAL IMMUNOLOGY, 2001, 13 (08) :1031-1042
[5]   Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis [J].
Behar, SM ;
Dascher, CC ;
Grusby, MJ ;
Wang, CR ;
Brenner, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1973-1980
[6]   MOUSE NK1(+) T-CELLS [J].
BENDELAC, A .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :367-374
[7]   NK cells and NKT cells in innate defense against viral infections [J].
Biron, CA ;
Brossay, L .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) :458-464
[8]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[9]   Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage [J].
Cecilia, D ;
Kewalramani, VN ;
O'Leary, J ;
Volsky, B ;
Nyambi, P ;
Burda, S ;
Xu, S ;
Littman, DR ;
Zolla-Pazner, S .
JOURNAL OF VIROLOGY, 1998, 72 (09) :6988-6996
[10]  
Emoto M, 1999, EUR J IMMUNOL, V29, P650, DOI 10.1002/(SICI)1521-4141(199902)29:02<650::AID-IMMU650>3.0.CO